Strategic Acquisitions Iktos has been actively acquiring companies such as Synsight, enhancing its capabilities in AI and new drug discovery. Leveraging these acquisitions can open doors for cross-selling products and services to a wider customer base.

Key Partnerships Through partnerships with industry giants like Elsevier and Bayer, Iktos has established a strong network within the pharmaceutical and biotech sectors. These partnerships present opportunities for collaborative selling and joint marketing efforts.

Industry Recognition Iktos received an award for collaboration in AI for new drug discovery. This recognition boosts the company's credibility and can be leveraged in sales pitches to showcase expertise and industry leadership.

Top Talent Recruitment With the hiring of Avirup Bose as Chief Business Officer, Iktos demonstrates a commitment to strengthening its sales and business development teams. Utilizing top talent can lead to enhanced sales strategies and improved customer acquisition.

Innovation Funding Having received investments from Merck Ventures and completed a Series A financing round, Iktos demonstrates financial stability and growth potential. This funding can be highlighted in sales conversations to instill confidence in customers regarding long-term partnerships.